Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | ALB | P02768 | 2/20 | 0.55 |
| ▸ | BLM | P54132 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.55 |
| ▸ | TK1 | P04183 | 3/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10171803 | 1.00 | LMNA (0.55) | LMNAALBBLMALDH1A1POLB | |
| SCHEMBL30688593 | 0.90 | LMNA (0.51) | LMNAALBBLMALDH1A1POLB | |
| SCHEMBL9311032 | 0.89 | TK1 (0.60) | LMNAALBBLMALDH1A1POLB | |
| SCHEMBL13102976 | 0.83 | TK1 (0.72) | LMNAALBBLMALDH1A1POLB | |
| SCHEMBL22382008 | 0.83 | TK1 (0.72) | LMNAALBBLMALDH1A1POLB | |
| SCHEMBL10650108 | 0.82 | TK1 (0.53) | LMNAALBBLMALDH1A1POLB | |
| SCHEMBL19565709 | 0.82 | TK1 (0.53) | LMNAALBBLMALDH1A1POLB | |
| SCHEMBL10666834 | 0.82 | TK1 (0.53) | LMNAALBBLMALDH1A1POLB | |
| SCHEMBL10662613 | 0.82 | TK1 (0.53) | LMNAALBBLMALDH1A1POLB | |
| SCHEMBL10662619 | 0.82 | TK1 (0.53) | LMNAALBBLMALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5246931-A | Triazine-substituted cyclobutane derivatives; viricides; side effect reduction | BRISTOL-MYERS SQUIBB COMPANY (US) | 1993-09-21 | — | — | US | disclosed |
| US-5153352-A | Viricides and antitumor agent | BRISTOL-MYERS SQUIBB COMPANY (US) | 1992-10-06 | — | — | US | disclosed |
| EP-0366059-A2 | Carbocyclic nucleoside analogs | BRISTOL-MYERS SQUIBB COMPANY (US) | 1990-05-02 | — | — | EP | disclosed |
| EP-0330992-A2 | Novel cyclobutane Derivatives, processes for their preparation and pharmaceutical compositions comprising them | Nippon Kayaku Kabushiki Kaisha (JP) | 1989-09-06 | — | — | EP | disclosed |